Opportunistic Valvular Screening: How Routine ECG-AI Expands the Structural Heart Pipeline
Dr. Dereck Mush, MD, MBA
What they do
Cardiomatics provides an AI platform that analyzes ECG recordings from various Holter monitors. Clinics, hospitals, and telemedicine providers use the software to automate arrhythmia detection and generate rapid, structured diagnostic reports for cardiologists.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Cloud ECG analysis
- Product type
- Software as a medical device
- Stage
- Series A
- Headquarters
- Krakow, Poland
- Region
- Europe
- Founded
- 2017
- Total funding
- $3M raised
Notable investors: Kaya VC, Nova Capital, Inovo Venture Partners, Innovation Nest.
Also in Cardiovascular
Related on The Signal
Dr. Dereck Mush, MD, MBA
The ECG-to-Echo Pathway: Where Tempus ECG-MR Must Prove Its Value
Dr. Dereck Mush, MD, MBA
The AI ECG Cardiology Market After Queen of Hearts: Who the De Novo Clearance Actually Benefits
Dr. Dereck Mush, MD, MBA
How Accurate Is Smartwatch Atrial Fibrillation Detection, Really?
Dr. Dereck Mush, MD, MBA